BR112017008747A2 - composições nutricionais contendo um prebiótico e lactoferrina e seus usos - Google Patents

composições nutricionais contendo um prebiótico e lactoferrina e seus usos

Info

Publication number
BR112017008747A2
BR112017008747A2 BR112017008747A BR112017008747A BR112017008747A2 BR 112017008747 A2 BR112017008747 A2 BR 112017008747A2 BR 112017008747 A BR112017008747 A BR 112017008747A BR 112017008747 A BR112017008747 A BR 112017008747A BR 112017008747 A2 BR112017008747 A2 BR 112017008747A2
Authority
BR
Brazil
Prior art keywords
lactoferrin
prebiotic
composition including
pediatric patient
compositions containing
Prior art date
Application number
BR112017008747A
Other languages
English (en)
Inventor
Wittke Anja
Berg Brian
Chichlowski Maciej
Waworuntu Rosaline
Jouni Zeina
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/535,717 external-priority patent/US20150119322A1/en
Priority claimed from US14/636,810 external-priority patent/US10709770B2/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of BR112017008747A2 publication Critical patent/BR112017008747A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

a presente invenção refere-se a uma composição e método para a modulação da expressão de receptor serotoninérgico, reduzindo o comportamento do tipo ansioso e resposta inflamatória induzida pelo estresse em um paciente pediátrico, o método incluindo administrar ao paciente pediátrico uma composição nutricional incluindo lactoferrina de uma fonte não humana e uma composição prebiótica incluindo polidextrose e/ ou galacto-oligossacarídeos. ainda fornecido é um método para a redução da constipação em um paciente pediátrico por fornecer uma composição nutricional incluindo lactoferrina de uma fonte não humana e uma composição prebiótica incluindo polidextrose e/ ou galacto-oligossacarídeos.
BR112017008747A 2014-11-07 2015-10-08 composições nutricionais contendo um prebiótico e lactoferrina e seus usos BR112017008747A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/535,717 US20150119322A1 (en) 2013-07-31 2014-11-07 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US14/636,810 US10709770B2 (en) 2013-07-31 2015-03-03 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
PCT/US2015/054628 WO2016073132A1 (en) 2014-11-07 2015-10-08 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

Publications (1)

Publication Number Publication Date
BR112017008747A2 true BR112017008747A2 (pt) 2017-12-19

Family

ID=54347872

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017008747A BR112017008747A2 (pt) 2014-11-07 2015-10-08 composições nutricionais contendo um prebiótico e lactoferrina e seus usos

Country Status (10)

Country Link
EP (1) EP3214951A1 (pt)
CN (1) CN107072282A (pt)
AU (1) AU2015343613A1 (pt)
BR (1) BR112017008747A2 (pt)
CA (1) CA2962136A1 (pt)
MX (1) MX2017005783A (pt)
PH (1) PH12017500763A1 (pt)
SG (1) SG11201702036QA (pt)
TW (1) TW201630617A (pt)
WO (1) WO2016073132A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE059584T2 (hu) * 2018-03-09 2022-11-28 Frimline Private Ltd Gyógyszerészeti készítmény vérszegénység kezelésére
CN110496227B (zh) * 2019-10-10 2022-06-14 河南科技学院 一种基于燕麦β-葡聚糖的澄清型疏水性多酚运载体系及其制备方法
MX2022013442A (es) * 2020-04-27 2022-11-30 Nestle Sa Metodo para producir productos similares a la leche.
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
EP1787532A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US5861491A (en) 1994-02-16 1999-01-19 Pharming B.V. Isolation of lactoferrin from milk
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
AU4498499A (en) 1998-06-18 2000-01-05 Upfront Chromatography A/S Expanded bed adsorption system
EP1289641A2 (en) 2000-05-12 2003-03-12 Upfront Chromatography A/S A bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
DK1584242T3 (da) 2001-06-01 2010-05-25 Upfront Chromatography As Fraktionering af proteinholdige blandinger
WO2003073866A1 (en) 2002-03-07 2003-09-12 Upfront Chromatography A/S A process of isolating lactoferrin
EP2251030A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
KR101143997B1 (ko) * 2010-03-04 2012-05-09 한미사이언스 주식회사 유산균 제제 및 5-ｈｔ4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
US8968722B2 (en) * 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
US9661874B2 (en) * 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof

Also Published As

Publication number Publication date
TW201630617A (zh) 2016-09-01
MX2017005783A (es) 2017-07-28
CA2962136A1 (en) 2016-05-12
CN107072282A (zh) 2017-08-18
PH12017500763A1 (en) 2017-10-09
WO2016073132A1 (en) 2016-05-12
SG11201702036QA (en) 2017-04-27
EP3214951A1 (en) 2017-09-13
AU2015343613A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
BR112017008284A8 (pt) Bifidobactérias ativadas e métodos para uso das mesmas
PH12018501299A1 (en) Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion
BR112016011195A2 (pt) Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
BR112015029611A2 (pt) composições para uso em ruptura de cartilagem
BR112015015870A2 (pt) composição farmacêutica
BR112017008747A2 (pt) composições nutricionais contendo um prebiótico e lactoferrina e seus usos
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112018006445A2 (pt) métodos para tratar distrofia muscular
BR112017002627A2 (pt) prebióticos para reduzir o risco de obesidade no futuro
BR112017010440A2 (pt) administração sublingual de riluzol
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
PH12015501334A1 (en) Milk-based nutritional compositions containing lactoferrin and uses thereof
EP3102220C0 (en) SYNERGIC FOOD SUPPLEMENT COMPOSITIONS FOR THE PREVENTION, TREATMENT OR REGULATION OF INFLAMMATORY DISORDERS
IL266441B (en) Synergistic herbal compositions with prebiotic properties for the treatment of acne
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
EP2986316A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND / OR PROPHYLAXIS OF A DIFFICULT CLOSTRIDIUM ASSOCIATED DISEASE
BR112017007025A2 (pt) sulfatos de colesterol oxigenados para terapia de distúrbios causados por pelo menos um de atividade de leptina atenuada e um distúrbio de armazenamento de lipídio
PH12016500766A1 (en) Age-tailored nutritional compositions with a varying protein content
BR112015022513A2 (pt) produto e método para tratamento de diarreia
BR112016000338A8 (pt) composto enriquecido em deutério de fórmula estrutural i, composição farmacêutica, e usos de um composto
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso
BR112015024434A2 (pt) composição de luteína adequada para formulações de alimentos para crianças
WO2014178007A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic
BR112015005355A2 (pt) composição prebiótica de tilacoíde

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements